LANDMARK: Risk levels of locally advanced disease using concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
LANDMARK: Changes in Laryngeal Cancer demographics and treatment
Laryngeal cancer in the United States: Changes in demographics, patterns of care and survival
LANDMARK: The RTOG 91-11 Trial – Treatments for advance laryngeal cancer for organ preservation
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
LANDMARK: The VA Trial – Optimal treatment for advance laryngeal cancer
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.
LANDMARK: Patient preference for speech versus survival in laryngeal cancer
Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer
Osteoradionecrosis (ORN) Grading
A grading system to describe the extent of osteoradionecrosis.